nanosymposium - Society for Neuroscience

9:00 E11 342.22 Bergmann glia plasticity: Glutamatedependent
glast down regulation. L. G. GARCIA*;
Z. MARTÍNEZ-LOZADA; C. HERNÁNDEZ-KELLY;
J. AGUILERA; A. ORTEGA*. CINVESTAV, Inst. de
Neurosciènces i Departament de Bioquímica i Biología Mol.
10:00 E12 342.23 Role of Na,K-ATPase isoforms for
intracellular sodium concentration and rate of glutamate
activated sodium-coupled transport in astrocytes. N. B.
ILLARIONOVA; S. ZELENIN; A. APERIA; E. GUNNARSON*.
Karolinska Institutet.
11:00 E13 342.24 Raloxifene neuroprotection by increased
glutamate transporter expression in astrocytes. S. L.
JAMES*; B. GRIFFIN; S. CHORNYY; L. EUN-SOOK.
Meharry Med. Col.
8:00 E14 342.25 Evaluation of glutamate transporter
EAAT2 translational activators in a mouse model of epilepsy.
Q. KONG*; D. SCHULTE; L. CHANG; G. D. CUNY; M. A.
GLICKSMAN; X. XING; C. G. LIN. The Ohio State University,
Dept. of Neurosci., Brigham & Women’s Hospital, Harvard
Med. Sch.
9:00 E15 342.26 Evaluation of glutamate transporter
EAAT2 translational activators in a mouse model of ALS. C.
G. LIN*; Q. KONG; L. CHANG; B. IBABAO; D. SCHULTE; L.
LAI; Y. LIN; K. TAKAHASHI; G. CUNY; M. GLICKSMAN; X.
XING. Ohio State Univ., Brigham & Women’s Hosp.
POSTER
343. Transporters: Monoamine
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 E16 343.01 Proteomic analysis of an interactome for
ssri-sensitive serotonin transporters. R. YE*; R. BLAKELY.
Vanderbilt Univ. Med. Ctr., Vanderbilt Univ. Med. Ctr.
9:00 E17 343.02 Single-molecule analysis of dopamine
transporter trafficking using ligand-conjugated quantum
dots. O. KOVTUN; I. D. TOMLINSON; D. SAKRIKAR; J. C.
CHANG; R. D. BLAKELY*; S. J. ROSENTHAL. Vanderbilt
Univ., Vanderbilt Univ., Vanderbilt Univ. Sch. Med. Ctr. Molec
Neurosci, Vanderbilt Univ. Sch. Med. Ctr. Molec Neurosci.
10:00 E18 343.03 Accelerated recycling and anomalous
amphetamine regulation of a novel ADHD-associated
dopamine transporter coding variant. D. SAKRIKAR*; M.
S. MAZEI-ROBISON; L. R. MILLER; M. A. MERGY; P. J.
HAMILTON; A. GALLI; M. GILL; R. D. BLAKELY. Vanderbilt
Univ., Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.,
Trinity Col., Vanderbilt Univ.
11:00 E19 343.04 Native immune system regulation of the
brain serotonin transporter. C. ZHU*; K. M. LINDLER; N. L.
BAGANZ; D. SAKRIKAR1; W. A. HEWLETT; E. DENERIS;
R. D. BLAKELY. Vanderbilt Univ., Vanderbilt Univ., Case
Western Reserve Univ., Vanderbilt Univ.
8:00 E20 343.05 A mouse model of ADHD derived from
the human dopamine transporter variant Ala559Val: Initial
characterization. M. A. MERGY*; T. N. JESSEN; J. WRIGHT;
C. S. ORAVEC; P. GRESCH; G. STANWOOD; A. GALLI; R.
D. BLAKELY. Vanderbilt Univ.
9:00 E21 343.06 Who DAT? a forward genetic screen
for presynaptic regulators of dopamine homeostasis. J.
A. HARDAWAY*, III; S. M. WHITAKER; S. R. BAAS; S. L.
HARDIE; D. B. FLAHERTY; R. D. BLAKELY. Vanderbilt
Univ., The Kinkaid Sch., Eckerd Col.
10:00 E22 343.07 Exploring mechanisms of amphetamine
action in intact Drosophila brain. M. S. SONDERS*; Z. Z.
FREYBERG; J. FLORES; A. CHEN; G. HU; H. FEI; B. D.
MCCABE; D. E. KRANTZ; D. SAMES; D. SULZER; J. A.
JAVITCH. Columbia Univ., Columbia Univ., Columbia Univ.,
UCLA, Columbia Univ., Suzhou Inst. of Nano-Tech and
Nano-Bionics, UCLA.
11:00 E23 343.08 Norepinephrine transporter A457P
knockin mouse: A model of a gene variant associated with
comorbid cardiovascular and psychiatric disorders. R. KLAR;
J. K. SHIREY-RICE; J. J. KRUEGER; N. M. WALLACE; M.
APPALSAMY; C. FINNEY; S. LONCE; A. DIEDRICH; D. H.
ROBERTSON; M. K. HAHN*. Vanderbilt Univ. Sch. of Med.,
Vanderbilt Univ. Sch. of Med., Vanderbilt Univ. Sch. of Med.
8:00 E24 343.09 Individual differences in impulsive
action and impulsive choice associated with dopamine and
serotonin transporter function in rat medial prefrontal and
orbitofrontal cortex. M. DARNA*; J. YATES; M. T. BARDO; L.
P. DWOSKIN. Univ. of Kentucky, Univ. of Kentucky.
9:00 E25 343.10 Amphetamine actions rely on the
availability of phosphatidylinositol-4,5-bisphosphate.
F. BUCHMAYER; K. SCHICKER; G. STÜBIGER; P. J.
HAMILTON; T. STEINKELLNER; H. J. MATTHIES; T.
MONTGOMERY; M. WINKLER; J. YANG; M. HOLY; G. F.
ECKER; A. GALLI; V. BOCHKOV; S. BOEHM; H. H. SITTE*.
Med. Univ. Vienna, Vanderbilt Univ., Univ. of Vienna.
10:00 E26 343.11 Acute administration of MDMA and
oral tryptophan supplement induces parallel changes in
serotonin levels in blood and brain tissue. J. M. ELLIOTT*;
S. PATTERSON; A. KIBRIA. De Montfort Univ.
11:00 E27 343.12 Comparison of serotonin transporter
function between human platelets and immortalized
lymphoblastoid cells. M. A. JAVORS*; N. HILL-
KAPTURCZAK; C. MATHIAS; D. RICHARD; P. TIAN; D.
GALINDO; D. DOUGHERTY. Univ. Texas Hlth. Sci. Ctr.,
Univ. of Texas HSC, Univ. of Texas HSC.
8:00 E28 343.13 Development of a real time, spatially
resolved fluorescent assay for vesicular packaging of
monoamines. A. I. BERNSTEIN*; K. A. STOUT; G. W.
MILLER. Emory Univ.
9:00 E29 343.14 A conserved asparagine in the first
transmembrane domain of the human serotonin transporter
is critical for cation selectivity in serotonin transport. B.
FELTS*; N. BURBACH; L. K. HENRY. Univ. of North Dakota
Sch. of Med.
10:00 E30 343.15 Stress-induced increase in serotonin
reuptake is kappa opioid receptor and p38alpha MAPK
mediated and underlies prodepressive and proaddictive
responses. A. G. SCHINDLER*; H. SHANKAR; D. I.
MESSINGER; M. MIYATAKE; R. M. GUSTIN; C. E. HAGAN;
J. F. NEUMAIER; C. CHAVKIN. Univ. of Washington.
11:00 E31 343.16 Linking Akt, monoamine transport
regulation, and mechanisms of abnormal behavior in the
neuronal Rictor null mouse. M. SIUTA*; O. DADALKO;
A. POE; I. REDDY; K. NIESNER; R. VAUGHAN; K.
NISWENDER; H. MATTHIES; A. GALLI. Vanderbilt Univ.,
Vanderbilt Univ., Univ. of North Dakota, Vanderbilt Univ.
20 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.